SRAM

Stone Ridge Asset Management Portfolio holdings

AUM $475M
This Quarter Return
-2.84%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$16.5M
AUM Growth
+$16.5M
Cap. Flow
-$12.2M
Cap. Flow %
-74.32%
Top 10 Hldgs %
38.05%
Holding
101
New
4
Increased
1
Reduced
14
Closed
45

Sector Composition

1 Consumer Discretionary 33.09%
2 Healthcare 20.37%
3 Communication Services 12.66%
4 Technology 12.24%
5 Consumer Staples 4.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.44T
$2.73M 16.57%
4,600
-500
-10% -$297K
NFLX icon
2
Netflix
NFLX
$513B
$562K 3.41%
5,500
-800
-13% -$81.7K
AMGN icon
3
Amgen
AMGN
$155B
$465K 2.82%
3,100
EQIX icon
4
Equinix
EQIX
$76.9B
$407K 2.47%
1,232
NVDA icon
5
NVIDIA
NVDA
$4.24T
$392K 2.38%
11,000
-800
-7% -$28.5K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$2.58T
$373K 2.26%
501
TSLA icon
7
Tesla
TSLA
$1.08T
$345K 2.09%
1,500
-300
-17% -$69K
JCP
8
DELISTED
J.C. Penney Company, Inc.
JCP
$337K 2.05%
30,500
-2,000
-6% -$22.1K
AGN
9
DELISTED
Allergan plc
AGN
$332K 2.01%
1,237
HUM icon
10
Humana
HUM
$36.5B
$327K 1.98%
1,788
TRIP icon
11
TripAdvisor
TRIP
$2.02B
$319K 1.94%
4,800
+1,300
+37% +$86.4K
FSLR icon
12
First Solar
FSLR
$20.9B
$288K 1.75%
4,200
BCR
13
DELISTED
CR Bard Inc.
BCR
$286K 1.74%
1,410
ORLY icon
14
O'Reilly Automotive
ORLY
$88B
$283K 1.72%
1,034
MNST icon
15
Monster Beverage
MNST
$60.9B
$280K 1.7%
+2,100
New +$280K
AVGO icon
16
Broadcom
AVGO
$1.4T
$280K 1.7%
1,812
-388
-18% -$60K
EXPE icon
17
Expedia Group
EXPE
$26.6B
$280K 1.7%
2,600
-600
-19% -$64.6K
RCL icon
18
Royal Caribbean
RCL
$98.7B
$279K 1.69%
3,400
ULTI
19
DELISTED
Ultimate Software Group Inc
ULTI
$271K 1.64%
1,401
CVS icon
20
CVS Health
CVS
$92.8B
$270K 1.64%
2,600
-5,000
-66% -$519K
TSN icon
21
Tyson Foods
TSN
$20.2B
$267K 1.62%
4,001
-1,000
-20% -$66.7K
GE icon
22
GE Aerospace
GE
$292B
$264K 1.6%
8,300
CELG
23
DELISTED
Celgene Corp
CELG
$260K 1.58%
2,600
UNH icon
24
UnitedHealth
UNH
$281B
$258K 1.57%
2,000
-1,200
-38% -$155K
REGN icon
25
Regeneron Pharmaceuticals
REGN
$61.5B
$252K 1.53%
700